Agios Pharmaceuticals
AGIO
#5065
Rank
HK$14.64 B
Marketcap
HK$245.24
Share price
-1.73%
Change (1 day)
-22.94%
Change (1 year)

Agios Pharmaceuticals (AGIO) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$0.64 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's total liabilities are HK$0.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agios Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.81 B-14.64%
2024-12-31HK$0.94 B-3.64%
2023-12-31HK$0.98 B-8.6%
2022-12-31HK$1.07 B-5.2%
2021-12-31HK$1.13 B-67.67%
2020-12-31HK$3.51 B80.39%
2019-12-31HK$1.94 B45.59%
2018-12-31HK$1.33 B-28.29%
2017-12-31HK$1.86 B-7.6%
2016-12-31HK$2.02 B247.76%
2015-12-31HK$0.58 B10.89%
2014-12-31HK$0.52 B-3.11%
2013-12-31HK$0.54 B-25.09%
2012-12-31HK$0.72 B-29.25%
2011-12-31HK$1.02 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$907.49 B 140,233.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$850.71 B 131,453.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$463.37 B 71,555.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
HK$1.74 B 169.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$5.10 B 689.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$42.39 B 6,455.28%๐Ÿ‡บ๐Ÿ‡ธ USA